XM
ALXN

XTX Markets’s Alexion Pharmaceuticals ALXN Stock Holding History

XTX Markets’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$219K Buy
+1,399
New +$180K 0.45% 115
2020
Q3 		– Sell
-3,020
Closed -$339K – 216
2020
Q2 		$339K Buy
+3,020
New +$321K 1.15% 17

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

XTX Markets's ALXN Position: Q4 2020 in Review

XTX Markets opened a new position in Alexion Pharmaceuticals (ALXN) in Q4 2020: 1,399 shares worth $219K. The stake represents 0.45% of the portfolio and ranks #115 among its holdings. This is a return to the name: XTX Markets previously reported a position in ALXN as recently as Q2 2020.

XTX Markets first reported a position in ALXN in Q2 2020 and has held it in 2 quarters since. The position peaked at $339K in Q2 2020. 825 funds tracked by Wall St. Rank hold ALXN as of Q4 2020.

  • XTX Markets held 1,399 shares of Alexion Pharmaceuticals worth $219K as of Q4 2020.
  • Alexion Pharmaceuticals was a new XTX Markets position in Q4 2020.
  • Alexion Pharmaceuticals made up 0.45% of XTX Markets's portfolio in Q4 2020, its #115 holding.
  • XTX Markets first reported a position in Alexion Pharmaceuticals in Q2 2020 and has held it in 2 quarters since.
  • XTX Markets's Alexion Pharmaceuticals position peaked at $339K in Q2 2020.
  • 825 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2020.

Based on XTX Markets's 13F filing for Q4 2020, filed 25 Jan 2021.